Neurogenic overactive bladder (OAB) is a chronic and distressing medical condition that has profound physical, emotional, and financial ramifications for patients and is commonly seen in patients with ...
Health-related quality of life (HRQOL) in patients with bladder cancer is important, because radical cystectomy and urinary diversion significantly affect urinary and sexual function, and lead to ...
Protect your bladder health with these 5 essential health checks. Learn which tests and screenings you need to maintain ...
DelveInsight’s, “Bladder Cancer Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers the ...
Bladder-outlet obstruction (BOO) in women has become an increasingly recognized entity over the past several years. This is partly because of the greater number of anti-incontinence surgeries being ...
Anticholinergic/antimuscarinic agents, the standard therapy for patients with neurogenic detrusor overactivity,15 are often used in conjunction with CIC to allow for ...
New York, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical ...
Incontinence is one of long-term care’s most difficult—and prevalent—challenges to address. A majority of residents will present needs for incontinence care—a difficult circumstance that is not made ...
An update from the phase 2 LEGEND trial shows that the investigational nonviral gene therapy detalimogene voraplasmid has achieved a 62% complete response rate at six months in patients with high-risk ...
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Bladder cancer pipeline constitutes 100+ key companies continuously working towards developing 100+ Bladder cancer ...
Appropriate management relies on an accurate diagnosis. In some patients with NGB, the original cause of their symptoms may be misdiagnosed, resulting in failure of initial therapy. 9 Assessment ...